Research findings also indicate that ovarian cancer patients with TILs exhibit increased intratumoral expression of INF-γ, IL-2, and T-cell-associated chemokines alongside having postponed disease recurrence and death while patients with no TIL have profiles of elevated levels of vascular endothelial growth factor (VEGF) expression (15). This evidence concerns the gene VEGFA and ovarian carcinoma.